These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39193503)

  • 1. Cloaking antibodies are prevalent in
    Pham A; Tan KKY; Ledger EL; Smith DJ; Reid DW; Burr L; Chambers DC; Wells TJ
    Front Cell Infect Microbiol; 2024; 14():1426773. PubMed ID: 39193503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.
    Zlosnik JE; Gunaratnam LC; Speert DP
    Front Cell Infect Microbiol; 2012; 2():67. PubMed ID: 22919658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
    J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Mediated Serum Resistance Protects Pseudomonas aeruginosa During Bloodstream Infections.
    Hickson SM; Hoehensteiger JK; Mayer-Coverdale J; Torres VVL; Feng W; Monteith JN; Henderson IR; McCarthy KL; Wells TJ
    J Infect Dis; 2024 Aug; 230(2):e221-e229. PubMed ID: 38235716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.
    Butler SL; Nelson JW; Poxton IR; Govan JR
    FEMS Immunol Med Microbiol; 1994 May; 8(4):285-92. PubMed ID: 7520313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
    Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J
    J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM; Lord R
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009529. PubMed ID: 26789750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Lord R; Jones AM; Horsley A
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009529. PubMed ID: 32239690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia.
    Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK
    Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP; Dos Santos SC; Madeira A; Mira NP; Moreira AS; Sá-Correia I
    Front Cell Infect Microbiol; 2011; 1():12. PubMed ID: 22919578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR; Brown AR; Jones AM
    Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
    Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ
    Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation.
    Saini LS; Galsworthy SB; John MA; Valvano MA
    Microbiology (Reading); 1999 Dec; 145 ( Pt 12)():3465-3475. PubMed ID: 10627044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients.
    Correia S; Nascimento C; Pereira L; Cunha MV; Sá-Correia I; Barreto C
    Rev Port Pneumol; 2008; 14(1):5-26. PubMed ID: 18265915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis.
    Maruri-Aransolo A; de Dios Caballero J; Michelena M; Medina-Pascual MJ; Carrasco G; Asensio O; Cols M; Cantón R;
    Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1349-1353. PubMed ID: 38780755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.